0001415889-21-000330.txt : 20210115 0001415889-21-000330.hdr.sgml : 20210115 20210115182727 ACCESSION NUMBER: 0001415889-21-000330 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210113 FILED AS OF DATE: 20210115 DATE AS OF CHANGE: 20210115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chapman Steven Leonard CENTRAL INDEX KEY: 0001711968 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37478 FILM NUMBER: 21533312 MAIL ADDRESS: STREET 1: 201 INDUSTRIAL ROAD, SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Natera, Inc. CENTRAL INDEX KEY: 0001604821 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 010894487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 INDUSTRIAL ROAD STREET 2: SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-249-9090 MAIL ADDRESS: STREET 1: 201 INDUSTRIAL ROAD STREET 2: SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 4 1 form4-01152021_030117.xml X0306 4 2021-01-13 0001604821 Natera, Inc. NTRA 0001711968 Chapman Steven Leonard C/O NATERA, INC. 201 INDUSTRIAL RD SUITE 410 SAN CARLOS CA 94070 true true false false CHIEF EXECUTIVE OFFICER Common Stock 2021-01-13 4 M 0 1118 10.41 A 38282 D Common Stock 2021-01-13 4 M 0 1042 10.73 A 39324 D Common Stock 2021-01-13 4 M 0 1526 9.29 A 40850 D Common Stock 2021-01-13 4 M 0 1042 13.01 A 41892 D Common Stock 2021-01-13 4 M 0 1042 20.27 A 42394 D Common Stock 2021-01-13 4 M 0 2385 25.46 A 45319 D Common Stock 2021-01-13 4 S 0 8155 115 D 37164 D Stock Option (right to buy) 10.41 2021-01-13 4 M 0 1118 0 D 2027-06-08 Common Stock 1118 9719 D Stock Option (right to buy) 10.73 2021-01-13 4 M 0 1042 0 D 2027-07-13 Common Stock 1042 4063 D Stock Option (right to buy) 9.29 2021-01-13 4 M 0 1526 0 D 2028-03-08 Common Stock 1526 47161 D Stock Option (right to buy) 13.01 2021-01-13 4 M 0 1042 0 D 2029-01-10 Common Stock 1042 52812 D Stock Option (right to buy) 20.27 2021-01-13 4 M 0 1042 0 D 2029-04-11 Common Stock 1042 59062 D Stock Option (right to buy) 25.46 2021-01-13 4 M 0 2385 0 D 2030-03-26 Common Stock 2385 39646 D The sales reported in this Form 4 effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 21, 2018 and the remaining shares vest in 36 equal monthly installments thereafter. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 12, 2018 and the remaining shares vest in 36 equal monthly installments thereafter. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter. The option shares vest over four years. 25% of the option shares vested and became exercisable on January 2, 2020 and the remaining shares vest in 36 equal monthly installments thereafter. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter. The option vests upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. As of October 1, 2020, the Company's Board of Director determined the performance criteria had been met with respect to 37,500 shares. /s/ Tami Chen, Attorney-in-Fact 2021-01-15